Deborah Wenk

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 12

Top Topics

Mass Spectrometry

Multiple Sclerosis

Top Venues

Journal of proteome research

This page only lists publications with an associated author ORCID identifier.

Publications

Deborah Wenk, Shahbaz Khan, Vladimir Ignatchenko, Taymaa May, Marcus Q Bernardini, Thomas Kislinger
Targeted Mass Spectrometry of Longitudinal Patient Sera Reveals LTBP1 as a Potential Surveillance Biomarker for High-Grade Serous Ovarian Carcinoma. Journal of proteome research (2024)
Deborah Wenk, Shahbaz Khan, Vladimir Ignatchenko, Taymaa May, Marcus Q Bernardini, Thomas Kislinger
Targeted Mass Spectrometry of Longitudinal Patient Sera Reveals LTBP1 as a Potential Surveillance Biomarker for High-Grade Serous Ovarian Carcinoma. Journal of proteome research 23 (2) (2024)
Deborah Wenk, Shahbaz Khan, Vladimir Ignatchenko, Taymaa May, Marcus Q Bernardini, Thomas Kislinger
Targeted Mass Spectrometry of Longitudinal Patient Sera Reveals LTBP1 as a Potential Surveillance Biomarker for High-Grade Serous Ovarian Carcinoma. Journal of proteome research 23 (2) (2024)
Deborah Wenk, Shahbaz Khan, Vladimir Ignatchenko, Taymaa May, Marcus Q Bernardini, Thomas Kislinger
Targeted Mass Spectrometry of Longitudinal Patient Sera Reveals LTBP1 as a Potential Surveillance Biomarker for High-Grade Serous Ovarian Carcinoma. Journal of proteome research 23 (2) (2024)
Deborah Wenk, Shahbaz Khan, Vladimir Ignatchenko, Taymaa May, Marcus Q Bernardini, Thomas Kislinger
Targeted Mass Spectrometry of Longitudinal Patient Sera Reveals LTBP1 as a Potential Surveillance Biomarker for High-Grade Serous Ovarian Carcinoma. Journal of proteome research 23 (2) (2024)
Deborah Wenk, Shahbaz Khan, Vladimir Ignatchenko, Taymaa May, Marcus Q Bernardini, Thomas Kislinger
Targeted Mass Spectrometry of Longitudinal Patient Sera Reveals LTBP1 as a Potential Surveillance Biomarker for High-Grade Serous Ovarian Carcinoma. Journal of proteome research 23 (2) (2024)
Deborah Wenk, Shahbaz Khan, Vladimir Ignatchenko, Harald Hübner, Peter Gmeiner, Dorothée Weikert, Monika Pischetsrieder, Thomas Kislinger
Phosphoproteomic Analysis of Dopamine D2 Receptor Signaling Reveals Interplay of G Protein- and β-Arrestin-Mediated Effects. Journal of proteome research (2022)
Deborah Wenk, Shahbaz Khan, Vladimir Ignatchenko, Harald Hübner, Peter Gmeiner, Dorothée Weikert, Monika Pischetsrieder, Thomas Kislinger
Phosphoproteomic Analysis of Dopamine D2 Receptor Signaling Reveals Interplay of G Protein- and β-Arrestin-Mediated Effects. Journal of proteome research 22 (1) (2022)
Deborah Wenk, Shahbaz Khan, Vladimir Ignatchenko, Harald Hübner, Peter Gmeiner, Dorothée Weikert, Monika Pischetsrieder, Thomas Kislinger
Phosphoproteomic Analysis of Dopamine D2 Receptor Signaling Reveals Interplay of G Protein- and β-Arrestin-Mediated Effects. Journal of proteome research 22 (1) (2022)
Deborah Wenk, Shahbaz Khan, Vladimir Ignatchenko, Harald Hübner, Peter Gmeiner, Dorothée Weikert, Monika Pischetsrieder, Thomas Kislinger
Phosphoproteomic Analysis of Dopamine D2 Receptor Signaling Reveals Interplay of G Protein- and β-Arrestin-Mediated Effects. Journal of proteome research 22 (1) (2022)
Deborah Wenk, Shahbaz Khan, Vladimir Ignatchenko, Harald Hübner, Peter Gmeiner, Dorothée Weikert, Monika Pischetsrieder, Thomas Kislinger
Phosphoproteomic Analysis of Dopamine D2 Receptor Signaling Reveals Interplay of G Protein- and β-Arrestin-Mediated Effects. Journal of proteome research 22 (1) (2022)
Deborah Wenk, Shahbaz Khan, Vladimir Ignatchenko, Harald Hübner, Peter Gmeiner, Dorothée Weikert, Monika Pischetsrieder, Thomas Kislinger
Phosphoproteomic Analysis of Dopamine D2 Receptor Signaling Reveals Interplay of G Protein- and β-Arrestin-Mediated Effects. Journal of proteome research 22 (1) (2022)